Speaker: Michele Bellantoni, MD
Moderator: Fatima Sheikh, MD, CMD
1-hour CME/CMD
Recorded: March 20, 2024
Released: March 27, 2024
Expiration: March 26, 2027
The session discusses management of two different patient populations:
- Those admitted for short-stay rehabilitation in skilled nursing facility following hospitalization for fracture.
- Long-term care residents at risk for falls and fractures.
Short-stay fracture patients are often not informed of their underlying osteoporosis and risk for future fractures. 15% of patients who experience a hip fracture will have a second hip fracture. Half of hip fracture patients experienced a prior fracture of a bone other than the femur but did not receive treatment for osteoporosis.
Long-term care residents with life-expectancy greater than 2 years can benefit from FDA approved osteoporosis medications to prevent fracture.
LEARNING OBJECTIVES
At the conclusion of this program, attendees should be able to:
- Identify appropriate short and long stay nursing facility residents who can benefit from FDA approved osteoporosis medications to prevent fractures.
- Establish a comprehensive osteoporosis treatment plan for nursing facility residents that includes bone heath nutrition, appropriate use of FDA approved osteoporosis medications, fall prevention, and weight bearing exercise.
- Identify appropriate short and long stay nursing facility residents for whom FDA approved osteoporosis medications should be withdrawn due to goals of care or duration of medication use
Financial Disclosure: None of the planners, faculty, or others in control of content disclosed a relevant financial relationship with an ineligible company.